When we talk about myopia getting worse, we are really talking about the eyeball itself growing longer than it should. Think of a ping-pong ball slowly stretching into the shape of an egg. As the eye elongates, light focuses in front of the retina instead of on it, and everything in the distance looks blurry. A stronger lens can correct the blur, but it does not change the fact that the eye is physically longer than normal.
Each step up in prescription is not just an inconvenience. Research published in the journal Ophthalmology in 2019 showed that every additional diopter of myopia increases the risk of retinal detachment by roughly three-fold and raises glaucoma risk by approximately 20 percent. Higher myopia also increases the chance of other conditions later in life, including cataracts and changes to the macula. Slowing progression now means lowering those risks for the decades ahead.
Myopia typically starts between ages six and twelve, when the eyes are growing fastest. Progression usually slows down in the late teens or early twenties once the eye stops growing. That means the years between diagnosis and early adulthood are the critical window. The earlier your child starts a myopia management plan, the more total progression you can prevent.
If your child's glasses prescription has gotten noticeably stronger at each annual exam, they are a strong candidate. Children whose myopia is progressing by half a diopter or more each year benefit the most from early intervention.
A child who becomes nearsighted at age six or seven has more years of potential growth ahead, which means more years for the prescription to climb. Starting management early gives those children the greatest opportunity to keep their final prescription lower.
Myopia has a strong genetic component. If one or both parents are nearsighted, their children face a higher likelihood of developing myopia and seeing it progress. Combined with modern lifestyle factors like increased screen time and less outdoor play, the risk compounds. Our eye doctors in the Enterprise and Paradise areas regularly evaluate children with these combined risk factors.
These custom-fit gas permeable lenses, known as orthokeratology or ortho-K, are worn only while your child sleeps. During the night, the lenses gently reshape the front surface of the cornea. When your child removes them in the morning, they can see clearly throughout the day without glasses or contacts. Beyond the convenience, this reshaping also changes the peripheral focus pattern in a way that has been shown to slow eye growth.
Specially designed soft contact lenses worn during the day can also slow progression. These lenses look and feel like regular soft contacts, but they have a unique optical design. The center of the lens corrects distance vision, while the surrounding zones create the peripheral focus changes that help slow eye growth. Many children adapt to wearing these lenses quickly, and they are available as daily disposables.
Atropine is a medication that has been used in eye care for decades. At very low concentrations, atropine drops used once at bedtime can slow myopia progression with minimal side effects. The drops work by relaxing certain receptors in the eye that influence growth. Some children use low-dose atropine on its own, while others use it in combination with specialty lenses for a stronger effect.
Newer spectacle lens designs incorporate multiple small focus zones across the lens surface. From the outside, they look like normal glasses. But the optical design creates peripheral defocus similar to myopia control contact lenses. These are a good option for younger children who are not ready for contacts or drops.
According to a 2022 review published in Progress in Retinal and Eye Research, myopia management treatments can slow progression by approximately 50 percent compared to standard glasses or contacts alone. The review analyzed clinical trials across orthokeratology, specialty soft lenses, atropine, and spectacle lens designs, and all four categories showed meaningful slowing of both prescription increase and axial eye growth. Individual results vary based on the child's age, rate of progression, and other factors.
The treatments used in myopia management have well-established safety profiles in children. Orthokeratology has been studied for over two decades in pediatric populations. Low-dose atropine at the concentrations used for myopia control causes far fewer side effects than the higher doses used for other purposes. The most common side effects, mild light sensitivity or slight difficulty focusing up close, are typically minor and manageable. Your eye doctor will monitor your child throughout treatment to ensure comfort and safety.
Your child's first visit includes a comprehensive eye exam along with measurements specific to myopia management. Our optometrists measure axial length, map the shape of the cornea, and assess how quickly the prescription has been changing. This baseline information helps determine which treatment approach is the best fit. Families in Southwest Las Vegas and the surrounding areas often start this process once they notice a pattern of annual prescription increases.
Most children adjust to their myopia management treatment within the first one to two weeks. For overnight reshaping lenses, the first few mornings may involve slightly fluctuating vision as the cornea settles into its new daytime shape. For daytime soft lenses, children often report that the lenses feel comfortable within the first few days. Atropine drops take only seconds to administer before bed.
Myopia management is not a one-time treatment. Your child will return for follow-up visits, typically every four to six months, so our team can measure axial length, check the prescription, and evaluate how well the treatment is working. If progression is not slowing as expected, the plan can be adjusted. This might mean changing the lens design, adjusting the atropine dose, or combining treatments. At Insight Vision Optometry, Las Vegas, our team tracks each patient's growth curve over time to make sure the approach stays on target.
The process starts with a thorough evaluation that goes beyond a standard eye exam. Our team measures your child's axial length, corneal shape, and current prescription. We also review the history of prescription changes to understand the rate of progression. This visit gives us the full picture we need to recommend a treatment path.
After the evaluation, our optometrists walk you through the options. We explain how each treatment works, what the daily routine looks like, and what kind of results to expect. Your child's age, maturity level, lifestyle, and the speed of their progression all factor into the recommendation. The decision is a shared effort between the doctor, the parent, and the child.
If the plan includes specialty lenses, your child will be fitted with their first set and trained on how to insert, remove, and care for them. For overnight lenses, we verify the fit and teach both parent and child the nightly cleaning routine. For atropine drops, we review the proper technique and dosing schedule. You leave this visit knowing exactly what to do at home.
Regular follow-up visits allow us to track your child's eye growth over months and years. We compare each axial length measurement to the previous one and adjust the treatment plan when needed. Most children continue myopia management until their late teens, when eye growth naturally slows. Insight Vision Optometry, Las Vegas serves families from across the Las Vegas valley who are committed to protecting their child's long-term vision.
